287 related articles for article (PubMed ID: 24931004)
41. Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer.
Cheung KF; Lam CN; Wu K; Ng EK; Chong WW; Cheng AS; To KF; Fan D; Sung JJ; Yu J
Cancer; 2012 Feb; 118(4):947-59. PubMed ID: 21717426
[TBL] [Abstract][Full Text] [Related]
42. UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation.
Zhou L; Shang Y; Jin Z; Zhang W; Lv C; Zhao X; Liu Y; Li N; Liang J
Cancer Biol Ther; 2015; 16(8):1241-51. PubMed ID: 26147747
[TBL] [Abstract][Full Text] [Related]
43. Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer.
Kanda M; Shimizu D; Nomoto S; Takami H; Hibino S; Oya H; Hashimoto R; Suenaga M; Inokawa Y; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Gastric Cancer; 2015 Apr; 18(2):288-96. PubMed ID: 24695972
[TBL] [Abstract][Full Text] [Related]
44. Intragenic DNA methylation concomitant with repression of ATP4B and ATP4A gene expression in gastric cancer is a potential serum biomarker.
Raja UM; Gopal G; Rajkumar T
Asian Pac J Cancer Prev; 2012; 13(11):5563-8. PubMed ID: 23317218
[TBL] [Abstract][Full Text] [Related]
45. The Reprimo-Like Gene Is an Epigenetic-Mediated Tumor Suppressor and a Candidate Biomarker for the Non-Invasive Detection of Gastric Cancer.
Alarcón MA; Olivares W; Córdova-Delgado M; Muñoz-Medel M; de Mayo T; Carrasco-Aviño G; Wichmann I; Landeros N; Amigo J; Norero E; Villarroel-Espíndola F; Riquelme A; Garrido M; Owen GI; Corvalán AH
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322837
[TBL] [Abstract][Full Text] [Related]
46. Protein expression and promoter methylation of the candidate biomarker TCF21 in gastric cancer.
Yang Z; Li DM; Xie Q; Dai DQ
J Cancer Res Clin Oncol; 2015 Feb; 141(2):211-20. PubMed ID: 25156819
[TBL] [Abstract][Full Text] [Related]
47. Methylation of CpG sites in RNF180 DNA promoter prediction poor survival of gastric cancer.
Deng J; Liang H; Ying G; Zhang R; Wang B; Yu J; Fan D; Hao X
Oncotarget; 2014 May; 5(10):3173-83. PubMed ID: 24833402
[TBL] [Abstract][Full Text] [Related]
48. XAF1 is frequently methylated in human esophageal cancer.
Chen XY; He QY; Guo MZ
World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
[TBL] [Abstract][Full Text] [Related]
49. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer.
Feng L; Yao C; Li P; Feng Y; Wang F; Liu YF; Guo YB; Mao QS; Xue WJ
Tumour Biol; 2016 Jul; 37(7):9399-410. PubMed ID: 26779638
[TBL] [Abstract][Full Text] [Related]
50. Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma.
Mo ML; Okamoto J; Chen Z; Hirata T; Mikami I; Bosco-Clément G; Li H; Zhou HM; Jablons DM; He B
PLoS One; 2013; 8(8):e71816. PubMed ID: 23977152
[TBL] [Abstract][Full Text] [Related]
51. KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome.
Ma G; Liu H; Hua Q; Wang M; Du M; Lin Y; Ge Y; Gong W; Zhao Q; Qiang F; Tao G; Zhang Z; Chu H
Mol Cancer; 2017 Feb; 16(1):46. PubMed ID: 28231797
[TBL] [Abstract][Full Text] [Related]
52. Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer.
Tanaka T; Nakamura J; Kitajima Y; Kai K; Miyake S; Hiraki M; Ide T; Koga Y; Noshiro H
Int J Oncol; 2013 Mar; 42(3):894-902. PubMed ID: 23291975
[TBL] [Abstract][Full Text] [Related]
53. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
54. TCTP promotes glioma cell proliferation in vitro and in vivo via enhanced β-catenin/TCF-4 transcription.
Gu X; Yao L; Ma G; Cui L; Li Y; Liang W; Zhao B; Li K
Neuro Oncol; 2014 Jan; 16(2):217-27. PubMed ID: 24311645
[TBL] [Abstract][Full Text] [Related]
55. Decreased Muc5AC expression is associated with poor prognosis in gastric cancer.
Kim SM; Kwon CH; Shin N; Park DY; Moon HJ; Kim GH; Jeon TY
Int J Cancer; 2014 Jan; 134(1):114-24. PubMed ID: 23801416
[TBL] [Abstract][Full Text] [Related]
56. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
[TBL] [Abstract][Full Text] [Related]
57. Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer.
Kanda M; Nomoto S; Oya H; Hashimoto R; Takami H; Shimizu D; Sonohara F; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Murotani K; Fujiwara M; Kodera Y
J Exp Clin Cancer Res; 2014 Oct; 33(1):88. PubMed ID: 25330808
[TBL] [Abstract][Full Text] [Related]
58. SAMD14 promoter methylation is strongly associated with gene expression and poor prognosis in gastric cancer.
Xu X; Chang X; Xu Y; Deng P; Wang J; Zhang C; Zhu X; Chen S; Dai D
Int J Clin Oncol; 2020 Jun; 25(6):1105-1114. PubMed ID: 32206938
[TBL] [Abstract][Full Text] [Related]
59. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer.
Du W; Wang S; Zhou Q; Li X; Chu J; Chang Z; Tao Q; Ng EK; Fang J; Sung JJ; Yu J
Oncogene; 2013 Jul; 32(28):3319-28. PubMed ID: 22907434
[TBL] [Abstract][Full Text] [Related]
60. Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer.
Wanajo A; Sasaki A; Nagasaki H; Shimada S; Otsubo T; Owaki S; Shimizu Y; Eishi Y; Kojima K; Nakajima Y; Kawano T; Yuasa Y; Akiyama Y
Gastroenterology; 2008 Aug; 135(2):580-90. PubMed ID: 18588891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
